Internal Medicine, Gastroenterology · Houston, TX
NPI
1063550291
Since 2007
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
444 Fm 1959 Rd, Suite A
Houston, TX, 77034
Phone (281) 481-9400
Groups this clinician bills Medicare through
Medicare paid, 2024
$133K
3,720 services
Medicare patients, 2024
307
Average age 73
Drug cost, 2024
$1.6M
3,271 prescriptions
Company payments, 2025
$73K
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jignesh P Shah was code 99490 (chronic, principal, and transitional care management), 231 times for 76 patients. In total Jignesh P Shah billed 3,720 services in 47 codes, and Medicare paid $133K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-06-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99490 Chronic, Principal, and Transitional Care Management | Office | 231 | 76 | $49.42 | $11K |
| 99214 Office E&M - Established | Office | 217 | 152 | $90.09 | $20K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 173 | 63 | $37.99 | $6,572 |
| 43239 Upper GI Endoscopy | Facility | 63 | 63 | $77.65 | $4,892 |
| 99204 Office E&M - New | Office | 63 | 63 | $109.89 | $6,923 |
| 45385 Colonoscopy - Lesion Removal | Facility | 58 | 58 | $203.18 | $12K |
| 99232 Hospital E&M - Subsequent | Facility | 46 | 29 | $58.32 | $2,683 |
| 99213 Office E&M - Established | Office | 38 | 34 | $69.41 | $2,638 |
| 99223 Hospital E&M - Initial | Facility | 31 | 31 | $129.62 | $4,018 |
| 99233 Hospital E&M - Subsequent | Facility | 29 | 26 | $92.73 | $2,689 |
| 99203 Office E&M - New | Office | 25 | 25 | $70.65 | $1,766 |
| 45380 Lower GI Endoscopy - Other | Facility | 23 | 23 | $102.68 | $2,362 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 16 | 16 | $171.76 | $2,748 |
By year: 2022 $153K for 4,067 services; 2023 $167K for 4,461 services; 2024 $133K for 3,720 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 109 | 36 | $28.17 | $3,070 |
| 88312 Surgical Pathology Examination | 24 | 14 | $71.67 | $1,720 |
| 88313 Surgical Pathology Examination | 24 | 14 | $57.07 | $1,370 |
Medicare prescription drug claims, 2024
In 2024, the drug Jignesh P Shah prescribed most often to Medicare patients was Omeprazole, with 1,074 prescriptions and refills. In total Jignesh P Shah wrote 3,271 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 1,074 | 2,250 | 364 | $22K |
| Pantoprazole Sodium Generic | 434 | 987 | 162 | $6,114 |
| Linzess Linaclotide | 223 | 356 | 66 | $191K |
| Dicyclomine Hcl Generic | 190 | 254 | 98 | $4,116 |
| Trulance Plecanatide | 157 | 177 | 61 | $97K |
| Ibsrela Tenapanor Hcl | 113 | 143 | 42 | $251K |
| Xifaxan Rifaximin | 93 | 93 | 16 | $293K |
| Plenvu Peg3350/Sod Sul/Nacl/Kcl/Asb/C | 84 | 84 | 79 | $11K |
| Dexlansoprazole Dr Dexlansoprazole | 79 | 127 | 18 | $20K |
| Mesalamine Generic | 67 | 116 | 18 | $15K |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 62 | 62 | 62 | $3,415 |
| Ondansetron Odt Ondansetron | 62 | 64 | 40 | $1,784 |
| Suflave Peg 3350/Sod Sulf,chlr/Pot/Mag | 54 | 54 | 52 | $6,572 |
| Esomeprazole Magnesium Generic | 52 | 114 | 19 | $3,415 |
| Lactulose Generic | 41 | 46 | 18 | $1,178 |
Brand drugs: 954 claims; generic drugs: 2,317 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jignesh P Shah $73K ($73K in general payments such as food, travel and fees) from 20 companies. The largest payer was Evoke Pharma, Inc. with $71K.
| Company | Payments | Amount |
|---|---|---|
| Evoke Pharma, Inc. EVOK | 69 | $71K |
| Abbvie Inc. ABBV | 30 | $515 |
| Madrigal Pharmaceuticals MDGL | 30 | $453 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 18 | $206 |
| Ardelyx, Inc. ARDX | 11 | $187 |
| Pfizer Inc. PFE | 11 | $176 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 6 | $163 |
| Janssen Biotech, Inc. JNJ | 9 | $143 |
| Genzyme Corporation SNY | 4 | $111 |
| Enterra Medical, Inc. | 1 | $52.6 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.